A systematic literature review of the human papillomavirus prevalence in locally and regionally advanced and recurrent/metastatic head and neck cancers through the last decade: The “ ALARM” study
Cancer Medicine · 2024
DOI: 10.1002/cam4.6916 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Cancer Medicine, 2024. Verfasst von Sofia Agelaki und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Translational Oncology, School of Medicine, University of Crete, Herakleion, Greece. Hauptthemen laut MEDLINE: Head and Neck Neoplasms, Human Papillomavirus Viruses, Oropharyngeal Neoplasms, Papillomavirus Infections. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 155 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Merck Sharp & Dohme LLC, a subsidiary of Merck & Co, Inc., Rahway, NJ, USA.
Abstract (Originalsprache)
Aims
The aim of this systematic literature review was to provide updated information on human papillomavirus (HPV) prevalence in locally and regionally advanced (LA) and recurrent/metastatic (RM) head and neck cancer (HNC) worldwide.
Methods
Electronic searches were conducted on clinicaltrials.gov , MEDLINE/PubMed, Embase, and ASCO/ESMO journals of congresses for interventional studies (IS; Phase I–III trials) as well as MEDLINE and Embase for non‐interventional studies (NIS) of LA/RM HNC published between January 01, 2010 and December 31, 2020. Criteria for study selection included: availability of HPV prevalence data for LA/RM HNC patients, patient enrollment from January 01, 2010 onward, and oropharyngeal cancer (OPC) included among HNC types. HPV prevalence per study was calculated as proportion of HPV+ over total number of enrolled patients. For overall HPV prevalence across studies, mean of reported HPV prevalence rates across studies and pooled estimate (sum of all HPV+ patients over sum of all patients enrolled) were assessed.
Results
Eighty‐one studies (62 IS; 19 NIS) were included, representing 9607 LA/RM HNC cases, with an overall mean (pooled) HPV prevalence of 32.6% (25.1%). HPV prevalence was 44.7% (44.0%) in LA and 24.3% (18.6%) in RM. Among 2714 LA/RM OPC patients from 52 studies with available data, mean (pooled) value was 55.8% (50.7%). The majority of data were derived from Northern America and Europe, with overall HPV prevalence of 46.0% (42.1%) and 24.7% (25.3%) across studies conducted exclusively in these geographic regions, respectively (Northern Europe: 31.9% [63.1%]). A “p16‐based” assay was the most frequently reported HPV detection methodology (58.0%).
Conclusion
Over the last decade, at least one quarter of LA/RM HNC and half of OPC cases studied in IS and NIS were HPV+. This alarming burden is consistent with a potential implication of HPV in the pathogenesis of at least a subgroup of HNC, underscoring the relevance of HPV testing and prophylaxis to HNC prevention and management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Translational Oncology, School of Medicine, University of Crete, Herakleion, Greece.
- Department of Medical Oncology, University General Hospital of Herakleion, Herakleion, Greece.
- Bioclinic Thessaloniki Medical Oncology Unit, Thessaloniki, Greece.
- Department of Medical Oncology, Mitera Hospital, Athens, Greece.
- MSD, Medical Affairs, Athens, Greece.
- MSD, Center for Observational and Real-World Evidence (CORE), Lyon, France.
ORCID-Profile: Charalampos Athanasopoulos
Förderung
- Merck Sharp & Dohme LLC, a subsidiary of Merck & Co, Inc., Rahway, NJ, USA
Zitieren
APA
Agelaki, S., Boukovinas, I., Athanasiadis, I., Trimis, G., Dimitriadis, I., Poughias, L., Morais, E., Sabale, U., Bencina, G., & Athanasopoulos, C. (2024). A systematic literature review of the human papillomavirus prevalence in locally and regionally advanced and recurrent/metastatic head and neck cancers through the last decade: The “ ALARM” study. Cancer Medicine. https://doi.org/10.1002/cam4.6916
Vancouver
Agelaki S, Boukovinas I, Athanasiadis I, Trimis G, Dimitriadis I, Poughias L, et al. A systematic literature review of the human papillomavirus prevalence in locally and regionally advanced and recurrent/metastatic head and neck cancers through the last decade: The “ ALARM” study. Cancer Medicine. 2024. doi:10.1002/cam4.6916
BibTeX
@article{Agelaki2024,
author = {Agelaki, Sofia and Boukovinas, Ioannis and Athanasiadis, Ilias and Trimis, Georgios and Dimitriadis, Ioannis and Poughias, Lazaros and Morais, Edith and Sabale, Ugne and Bencina, Goran and Athanasopoulos, Charalampos},
title = {A systematic literature review of the human papillomavirus prevalence in locally and regionally advanced and recurrent/metastatic head and neck cancers through the last decade: The “ ALARM” study},
journal = {Cancer Medicine},
year = {2024},
doi = {10.1002/cam4.6916}
}
EUVIMED